- 5 Posts
- 1 Photos
- 0 Videos
- staff
- Lives in hongkong
- From 52513
- Male
- 06/10/2003
- Followed by 0 people
Recent Updates
- Median PFS of 28.18 Months! How Do Phase III Data from Dalpiciclib Define a New Standard for HR+ Breast Cancer?Among female malignant tumors, breast cancer consistently ranks first in incidence, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer accounting for about 70%. Treatment for these patients primarily relies on endocrine therapy, but advanced patients are prone to developing resistance, leading to treatment bottlenecks. The emergence of...0 Comments 0 Shares 126 Views 0 ReviewsPlease log in to like, share and comment!
- Ripretinib: A Breakthrough Targeted Therapy for Gastrointestinal Stromal TumorsIn the field of targeted therapies for malignant tumors, the advent of ripretinib (QINLOCK) has brought renewed hope to patients with gastrointestinal stromal tumors (GIST). In particular, it provides a critical treatment option for patients whose disease continues to progress after multiple lines of therapy. As a broad-spectrum kinase inhibitor with a novel and innovative mechanism of action,...0 Comments 0 Shares 385 Views 0 Reviews
- Sending Medicines from China to the UK: A GuideThe key to sending medicines from China to the UK is ensuring their legality, compliant packaging, and choosing a reliable mailing channel. Dengyue Pharma provides this detailed guide: I. Pre-shipment Preparation Confirming Medicine Legality: Only medicines legally circulated in China (such as Lianhua Qingwen capsules, antihypertensive drugs, cold medicines, etc.) are permitted. Original...0 Comments 0 Shares 943 Views 0 Reviews
- Breakthrough in Chinese Influenza Drug Innovation: Sebaloxavir Marbaxil Tablets Usher in a New Era of TreatmentIn the field of influenza treatment, Sebaloxavir Marbaxil Tablets (trade name: Jikeshu), independently developed in China, marks a significant technological breakthrough, providing a new solution for global public health. As an innovative drug, it was approved for marketing by the National Medical Products Administration in July 2025. Specifically designed for adults with uncomplicated...0 Comments 0 Shares 1038 Views 0 Reviews
-
More Stories
Sponsored